Skip to main content
Clinical Trials/IRCT20221011056144N1
IRCT20221011056144N1RecruitingPhase 2

Comparison of the effect of albumin administration on attenuation, lung involvement and blood oxygenation of patients with Covid-19 admitted to intensive care unit with albumin level less than 3 and 2 g dl ( Clinical Trial )

Karaj University of Medical Sciences0 sites52 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
52

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Age 18 years and above
  • PCR test positive
  • Observation of lung involvement in CT scan
  • Hypoxia (arterial oxygen saturation less than 90%)
  • Patients with consent to participate in the study

Exclusion Criteria

  • Hypoxia (arterial oxygen saturation more than 90%)

Investigators

Sponsor
Karaj University of Medical Sciences

Similar Trials